Please login to the form below

implant

This page shows the latest implant news and features for those working in and with pharma, biotech and healthcare.

FDA approves Allergan’s biodegradable glaucoma implant drug

Durysta (bimatoprost implant) is the first biodegradable, sustained-release implant for IOP in patients with open-angle glaucoma or ocular hypertension. ... As the first FDA-approved intracameral, biodegradable sustained-release implant providing

Latest news

Bayer bulks up in women’s health again with non-hormonal contraceptive deal

The German drugmaker is already a major player in the women’s health market, selling a range of contraceptive products including oral and injectable hormonal products and implants, and is one ... Bayer hasn’t had the happiest recent history in the
Servier faces manslaughter trial over weight loss drug deaths

from defective breast implants manufactured by Poly Implant Prothese (PIP).
HIV meeting hears progress towards vaccine and cure

Meanwhile, Merck &Co/MSD presented preliminary results with a new HIV drug – islatravir (MK-8591) – that it believes could offer a year of anti-HIV activity from a single implant, rather
Elon Musk’s NeuraLink applies to trial ‘brain-machine interface’

to surgically implant the threads that is “as simple and automated as LASIK” – the laser surgery commonly used for vision correction – and eventually might not even need anaesthesia. ... The basic concepts on offer at NeuraLink aren’t
CHMP nod for Alexion, GSK drugs, revocation for Lartruvo

Other drugs gaining recommendation included:. Molteni Farmaceutici’s Sixmo (buprenorphine) an opioid dependence implant treatment that releases low levels of buprenorphine into the patient’s body for six months.

More from news
Approximately 1 fully matching, plus 94 partially matching documents found.

Latest Intelligence

The transatlantic opioid crisis

such as the group litigation order (GLO) for silicone breast implants.
Delivering the promise of regenerative medicine

Once only imaginable in science fiction, the latest applications include engineered skin tissue to treat burns victims, custom-grown bones for implants and joint replacements, personalised dietary treatments using gut bacteria
Changes to look out for in Medical Devices Regulations

PIP. In 2000, it was discovered that Poly Implant Prothèse (PIP) had been using industrial-grade silicone instead of the medical-grade specified for the CE mark in the manufacture of ... The CE mark for PIP implants was consequently withdrawn, and
Tightening medical device safety

Building on the lessons learned from recent events (such as the French PIP breast implant scandal), the EU regulations require that each device bears a unique device identifier (UDI) and that ... In this regard, medical device users of implantable
Deal Watch - May 2017

its bupivacaine collagen implant for treatment of post-operative pain. ... Innocoll (US/IE). Gurnet Point (US). Company acquisition. Company with US pre-registration bupivacaine collagen implant for post-operative pain.

More from intelligence
Approximately 0 fully matching, plus 15 partially matching documents found.

Latest appointments

Promimic appoints CEO

Larsson joins the nano-materials developer from Dentsply Sirona Implants, where he was most recently director for global market development. ... Magnus brings valuable global leadership experience and a wide network from his time in the dental implant
Histogenics names former MedImmune president as CEO

This includes lead candidate NeoCart – a cartilage tissue implant in phase III trials.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

RWE Blog 1: Real-world challenges and real-world data

Greater improvement of key clinical outcomes in patients with diabetic macular oedema from a real-world study of a fluocinolone intravitreal implant, compared with the results of the FAME (Fluocinolone Acetonide

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company

An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

Surviving cancer: a new era for patients: Now more than ever, a shift in perspective is needed...
Crisis? No problem!: Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?: First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....